Press release
Chronic Rhinosinusitis With Nasal Polyps Market Expansion Continues, with Forecast Valuation of $6.21 Billion by 2029
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.Chronic Rhinosinusitis With Nasal Polyps Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, we have observed significant growth in the market size of chronic rhinosinusitis with nasal polyps. The market, which is forecasted to increase from $4.02 billion in 2024 to hit $4.4 billion by 2025, boasts a compound annual growth rate (CAGR) of 9.3%. This growth experienced in the historical period stems from a higher prevalence rate, advancements in diagnostic methods, strides in treatment innovation, improved patient understanding, and an upsurge in spending on healthcare.
Chronic Rhinosinusitis With Nasal Polyps Market Size Forecast: What's the Projected Valuation by 2029?
In the ensuing years, the market for chronic rhinosinusitis with nasal polyps is anticipated to witness robust growth. The projected Compound Annual Growth Rate (CAGR) is 9.0% which will result in reaching $6.21 billion by 2029. The projected surge can be linked to several factors such as the rise of biologic therapies, personal medicine proliferation, technological advancements, increased regulatory approvals, patient-centric care, and continual tracking of epidemiology trends. Key trends for the period under forecast consist of novel drug distribution systems, an increased understanding of pathophysiology, clinical assessments, long-term studies, growing awareness, integrated healthcare models, and tracking prevalence and incidence.
View the full report here:
https://www.thebusinessresearchcompany.com/report/chronic-rhinosinusitis-with-nasal-polyps-global-market-report
What Are the Drivers Transforming the Chronic Rhinosinusitis With Nasal Polyps Market?
The growth of the chronic rhinosinusitis with nasal polyps market is slated to be driven by an escalating prevalence of respiratory diseases. The spectrum of respiratory diseases is vast, impacting diverse elements of the respiratory system, notably the lungs and airways. A complex mix of contributors such as air pollution, cigarette smoke, global warming, infections, job-related exposures, and allergies lead to an upsurge in respiratory disease incidents. It is observed that there is also an corresponding rise in related conditions like CRSwNP owing to a higher number of people suffering from ailments like asthma and chronic obstructive pulmonary disease (COPD). Consequently, there is an increased need for diagnostic utilities, therapeutic methods, and surgical procedures. For instance, data released by the National Center for Health Statistics (NCHS), a health statistics institution based in the U.S., endorsed that the incidence of present asthma in adults of 18 years and above in the United States amplified from 8.4% in 2021 to 8.7% in 2022 in May 2024. Additionally, instances of asthma in the adult demographic escalated from 3.3% in 2021 to 3.7% in 2022. Hence, the soaring prevalence of respiratory infections will stimulate the growth of the chronic rhinosinusitis with nasal polyps market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17113&type=smp
What Long-Term Trends Will Define the Future of the Chronic Rhinosinusitis With Nasal Polyps Market?
Prominent firms in the chronic rhinosinusitis with nasal polyps market are zeroing in on substitute therapies such as anti-IL-5 biologics to enhance patient results and secure a market edge. Anti-IL-5 biologics provide specialized treatment that mitigates eosinophilic inflammation in conditions like severe asthma and eosinophilic disorders, therefore boosting symptom management and patient's quality of life. For example, in March 2024, Optinose, a pharmaceutical company based out of the US specializing in the development and commercialization of advanced products, was granted approval by the U.S. Food and Drug Administration (FDA) for its XHANCE, a prescription nasal spray intended for adult chronic rhinosinusitis (CRS) treatment, especially for both chronic rhinosinusitis with nasal polyps (CRSwNP) and chronic rhinosinusitis without nasal polyps (CRSsNP). It includes fluticasone propionate, an anti-inflammatory corticosteroid that alleviates inflammation in the nasal pathway. A key characteristic is its unique Exhalation Delivery System (EDS) that enables patients to exhale into the device when dispensing the spray, improving the delivery of medication deep inside the nasal canal, and efficiently focusing on the regions where nasal polyps develop and sinuses drain.
Which Segments in the Chronic Rhinosinusitis With Nasal Polyps Market Offer the Most Profit Potential?
The chronic rhinosinusitis with nasal polyps market covered in this report is segmented -
1) By Treatment: Medications, Surgical Methods
2) By Route Of Administration: Nasal, Oral, Other Routes Of Administration
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Medications: Corticosteroids (Nasal Sprays, Oral Steroids), Biologics (Monoclonal Antibodies Like Dupilumab), Antibiotics, Antihistamines, Leukotriene Modifiers
2) By Surgical Methods: Endoscopic Sinus Surgery (ESS), Polypectomy (Polyps Removal), Balloon Sinuplasty
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=17113&type=smp
Which Firms Dominate the Chronic Rhinosinusitis With Nasal Polyps Market by Market Share and Revenue in 2025?
Major companies operating in the chronic rhinosinusitis with nasal polyps market are Pfizer Inc., Roche Holding AG, Merck & Co Inc, Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Medtronic plc, Boehringer Ingelheim International GmbH, Amgen Inc, Teva Pharmaceutical Industries Ltd, Regeneron Pharmaceuticals Inc, Daiichi Sankyo Company Limited, Olympus Corporation, Eisai Co Ltd, Smith & Nephew PLC, Genentech USA Inc, Mallinckrodt Pharmaceuticals, Lyra Therapeutics Inc, Sunovion Pharmaceuticals, Acclarent Inc., Optinose US Inc, SinuSys Corporation, Biohaven Pharmaceuticals
Which Regions Offer the Highest Growth Potential in the Chronic Rhinosinusitis With Nasal Polyps Market?
North America was the largest region in the chronic rhinosinusitis with nasal polyps market in 2023. The regions covered in the chronic rhinosinusitis with nasal polyps market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17113
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chronic Rhinosinusitis With Nasal Polyps Market Expansion Continues, with Forecast Valuation of $6.21 Billion by 2029 here
News-ID: 4132561 • Views: …
More Releases from The Business Research Company

Transformative Trends Impacting the Clinical Trial Equipment And Ancillary Solut …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Clinical Trial Equipment And Ancillary Solutions Market Size By 2025?
The market size for clinical trial equipment and ancillary solutions has seen substantial growth in the past few years. The value is projected to rise from $2.54 billion in 2024 to $2.78 billion in 2025,…

2025-2034 Dermatophytosis Treatment Market Evolution: Disruptions, Innovations, …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Dermatophytosis Treatment Market Through 2025?
The market size for dermatophytosis treatment has seen substantial growth lately. It's projected that it will elevate from a worth of $10.38 billion in 2024 to $11.07 billion in 2025, showcasing a compound annual growth rate (CAGR)…

Future of the Clothing Footwear Accessories Market: Strategic Analysis and Forec …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Clothing Footwear Accessories Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size of the clothing, footwear, and accessories sector has seen robust growth in the previous years. The projections suggest the market will expand from a value of $2128.13 billion in 2024 to…

Dental Polishing Machine Market Expected to Achieve 6.9% CAGR by 2029: Growth Fo …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Dental Polishing Machine Market Size By 2025?
Recent years have seen a robust expansion in the dental polishing machine market size. The market, valued at $3.33 billion in 2024, is expected to witness an increase to $3.57 billion in 2025, reflecting a compound annual growth…
More Releases for Nasal
External Nasal Dilator and Nasal Strip Research:CAGR of 5.9% during the forecast …
QY Research Inc. (Global Market Report Research Publisher) announces the release of 2025 latest report "External Nasal Dilator and Nasal Strip- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031". Based on current situation and impact historical analysis (2020-2024) and forecast calculations (2025-2031), this report provides a comprehensive analysis of the global Wire Drawing Dies market, including market size, share, demand, industry development status, and forecasts for the…
Nasal Polyposis Market 2034 | Nasal Polyposis Therapies, Clinical trials, Nasal …
As per DelveInsight, the Nasal Polyposis Market is anticipated to grow immensely in the coming years owing to the launch of upcoming therapies and the increase in the incident population of Nasal Polyposis in the 7MM.
DelveInsight's "Nasal Polyposis Market Insights, Epidemiology, and Market Forecast 2034 [https://www.delveinsight.com/report-store/nasal-polyposis-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Nasal Polyposis market size, share, trends, and growth…
External Nasal Dilator and Nasal Strip Market Size, Players, Revenue Analysis 20 …
External Nasal Dilator and Nasal Strip Market Overview 2023:
The External Nasal Dilator and Nasal Strip Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the External Nasal Dilator and Nasal Strip market. This report…
Nasal Drug Delivery Market - Effortless Delivery, Optimal Results: Nasal Drug De …
Newark, New Castle, USA - new report, titled Nasal Drug Delivery Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Nasal Drug Delivery market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Nasal Drug Delivery market. The report offers an overview of…
Nasal Aspirators Market: Effective Solutions for Infant Nasal Congestion | Smith …
Allied Market Research Analyst have added a new research study on Title Nasal Aspirators Market, Global Outlook and Forecast 2023-2030 with detailed information & Key Players Such as B. Braun Melsungen, A. Titan Instruments, Altay Scientific Group, Neilmed Pharmaceuticals, Smith & Nephew, Koninklijke Philips, B.Well Swiss AG, KLS Martin Group, ResMed, and Avita Medical. The Study provides in-depth comprehensive analysis includes Clear Market definitions, classifications, manufacturing processes, cost structures, development…
Nasal Care Device Market Promoting Nasal Health and Hygiene with Innovative Devi …
Global Nasal Care Device Market Overview:
The Nasal Care Device market is a broad category that includes a wide range of products and services related to various industries. This market comprises companies that operate in areas such as consumer goods, technology, healthcare, and finance, among others.
In recent years, the Nasal Care Device market has experienced significant growth, driven by factors such as increasing consumer demand, technological advancements, and globalization. This growth…